Variant report

Variant	nsv1025270
Chromosome Location	chr6:64574202-64608983
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:3)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:64577143..64578862-chr6:64579114..64581056,2	MCF-7	breast:
2	chr6:64570354..64572427-chr6:64574035..64576622,2	K562	blood:
3	chr6:64577143..64578862-chr6:64579114..64581056,2	MCF-7	breast:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PHF3-9	chr6:64589092-64590494	NONHSAT113359
2	lnc-PHF3-9	chr6:64574688-64574738	NONHSAT113359
3	lnc-PHF3-9	chr6:64585190-64585257	ucscGeneNc_uc010kai_1
4	lnc-PHF3-9	chr6:64589092-64590517	ucscGeneNc_uc010kai_1

No data

Extended variants
information (count: 585 )
Associated
traits (count: 79 )

Variant overlapped rSNPs/rCNVs (count:585 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs398123575	chr6:64574212-64574213	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs139056492	chr6:64574266-64574267	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs370064396	chr6:64574270-64574271	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs541679940	chr6:64574334-64574335	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs562959861	chr6:64574337-64574338	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs200571023	chr6:64574389-64574390	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs369795317	chr6:64574392-64574393	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs374537625	chr6:64574396-64574397	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs371429275	chr6:64574397-64574398	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs116055997	chr6:64574414-64574415	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs558092539	chr6:64574484-64574485	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs115584034	chr6:64574540-64574541	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs577877867	chr6:64574543-64574544	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs143979639	chr6:64574590-64574591	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs548014365	chr6:64574630-64574631	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs566238057	chr6:64574651-64574652	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs536958944	chr6:64574685-64574686	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs570581374	chr6:64574703-64574704	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
19	rs75690837	chr6:64574747-64574748	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs377327649	chr6:64574769-64574770	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs570058120	chr6:64574834-64574835	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs184069500	chr6:64574838-64574839	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs115643978	chr6:64574847-64574848	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs139407234	chr6:64574904-64574905	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs534750982	chr6:64574931-64574932	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs552760718	chr6:64574952-64574953	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs150071992	chr6:64574991-64574992	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs187704023	chr6:64575013-64575014	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs563220987	chr6:64575040-64575041	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs201223013	chr6:64575057-64575058	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs192219604	chr6:64575113-64575114	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs564061425	chr6:64575167-64575168	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs528182302	chr6:64575236-64575237	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs184415002	chr6:64575279-64575280	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs188812094	chr6:64575325-64575326	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs574683445	chr6:64575328-64575329	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs530292766	chr6:64575346-64575347	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs5876871	chr6:64575356-64575357	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs397748468	chr6:64575366-64575367	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs398110191	chr6:64575367-64575368	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs78406641	chr6:64575368-64575369	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs548931303	chr6:64575411-64575412	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs570246802	chr6:64575416-64575417	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs537502407	chr6:64575418-64575419	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs552293951	chr6:64575431-64575432	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs570787218	chr6:64575441-64575442	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs321503	chr6:64575442-64575443	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs553022928	chr6:64575483-64575484	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs574320195	chr6:64575517-64575518	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs535256436	chr6:64575536-64575537	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:79)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Autism	22495311	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Gastric cancer	17908304	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Systemic lupus erythematosus	17503323	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Melanoma	18172304	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Cancer	21637783	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Colorectal cancer	16272173	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
T-cell lymphomas	19863542	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Ependymoma	16718352	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	21364760	CNVD
Cancer	20164920	CNVD
Prostate cancer	16573809	CNVD
Ovarian cancer	19835627	CNVD
Acute myeloid leukemia	20729466	CNVD
Myelofibrosis	22110671	CNVD
Cancer	21183584	CNVD
Glioblastoma multiforme	22286061	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Breast cancer	16272173	CNVD
Developmental delay	21147756	CNVD
small cell lung cancer	20016488	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:44 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:64574000-64575000	Enhancers	Fetal Heart	heart
2	chr6:64574200-64575200	Enhancers	Fetal Brain Male	brain
3	chr6:64574800-64575200	Enhancers	Adipose Nuclei	Adipose
4	chr6:64575000-64579800	Weak transcription	Fetal Heart	heart
5	chr6:64576400-64577000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
6	chr6:64576600-64577000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
7	chr6:64579200-64580000	Enhancers	Pancreatic Islets	Pancreatic Islet
8	chr6:64579800-64581000	Enhancers	Fetal Heart	heart
9	chr6:64588600-64588800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
10	chr6:64588800-64589000	ZNF genes & repeats	H1 Cell Line	embryonic stem cell
11	chr6:64590200-64591200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
12	chr6:64590200-64591400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
13	chr6:64592200-64592600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
14	chr6:64592600-64593000	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
15	chr6:64593000-64593800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
16	chr6:64593000-64593800	Enhancers	GM12878-XiMat	blood
17	chr6:64595600-64597600	Enhancers	Fetal Lung	lung
18	chr6:64596400-64596600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
19	chr6:64597200-64597400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
20	chr6:64597600-64598000	Enhancers	HUES6 Cell Line	embryonic stem cell
21	chr6:64597800-64598200	Enhancers	HepG2	liver
22	chr6:64607200-64607600	Enhancers	Skeletal Muscle Female	skeletal muscle
23	chr6:64607200-64607800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
24	chr6:64607400-64608000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
25	chr6:64607600-64607800	Weak transcription	Skeletal Muscle Female	skeletal muscle
26	chr6:64607600-64607800	Enhancers	HMEC	breast
27	chr6:64607600-64608200	Enhancers	Muscle Satellite Cultured Cells	--
28	chr6:64607600-64608400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
29	chr6:64607800-64608000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
30	chr6:64607800-64608000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
31	chr6:64607800-64608200	Enhancers	Skeletal Muscle Female	skeletal muscle
32	chr6:64607800-64608800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
33	chr6:64608000-64608400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
34	chr6:64608000-64609000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
35	chr6:64608000-64609000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
36	chr6:64608200-64609000	Weak transcription	Skeletal Muscle Female	skeletal muscle
37	chr6:64608200-64609200	Weak transcription	HMEC	breast
38	chr6:64608400-64608800	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
39	chr6:64608400-64609200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
40	chr6:64608800-64609600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
41	chr6:64608800-64609800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
42	chr6:64608800-64610000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
43	chr6:64608800-64610000	Enhancers	Primary hematopoietic stem cells short term culture	blood
44	chr6:64608800-64610000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links